Aspirin Use and Colorectal Cancer Survival According to Tumor CD274 (Programmed Cell Death 1 Ligand 1) Expression Status.
about
The colorectal cancer immune microenvironment and approach to immunotherapies.The potential role of platelets in the consensus molecular subtypes of colorectal cancer.Aspirin in the era of immunotherapy.Histopathological and genotypic characterization of metastatic colorectal carcinoma with PD-L1 (CD274)-expression: Possible roles of tumour micro environmental factors for CD274 expression.Aspirin exerts high anti-cancer activity in PIK3CA-mutant colon cancer cells.Association Between Coffee Intake After Diagnosis of Colorectal Cancer and Reduced mortality.Colorectal Cancers: An Update on Their Molecular Pathology.Colorectal cancer prevention: Immune modulation taking the stage.Integrative analysis of exogenous, endogenous, tumour and immune factors for precision medicine.Tumor PDCD1LG2 (PD-L2) Expression and the Lymphocytic Reaction to Colorectal Cancer.Prediagnosis Use of Statins Associates With Increased Survival Times of Patients With Pancreatic Cancer.Integration of pharmacology, molecular pathology, and population data science to support precision gastrointestinal oncology.Dual antiplatelet therapy with clopidogrel and aspirin increases mortality in 4T1 metastatic breast cancer-bearing mice by inducing vascular mimicry in primary tumour.Contribution to Tumor Angiogenesis From Innate Immune Cells Within the Tumor Microenvironment: Implications for Immunotherapy.Colorectal cancer: genetic abnormalities, tumor progression, tumor heterogeneity, clonal evolution and tumor-initiating cells.Systematic review update of observational studies further supports aspirin role in cancer treatment: Time to share evidence and decision-making with patients?Clinically Relevant Anti-Inflammatory Agents for Chemoprevention of Colorectal Cancer: New Perspectives
P2860
Q38638847-9FF2AE9C-75DB-4BAA-9909-A85B2C433654Q39417307-ADA5B947-5280-4CDA-93CA-269E3C2CF67AQ43990306-8451EDDC-53BF-4F36-B14E-9FEECDC84E5AQ47127609-B197E894-547C-4CA8-860B-7DC3AE6F7ACDQ47171553-D02FECF8-175F-490A-A432-BFDBF07A81B0Q47439755-1BEA6D3B-E60C-49AB-AD61-32713D1ADBC5Q48182864-717E22FF-3AE5-4424-B84F-8D5A8234A1E8Q49391998-23E9608C-0A63-4396-93DE-74932BCE4D03Q50043586-2DD3AF58-BBA4-414F-B409-5148CCFF7B80Q50077322-138067F7-F885-4B73-844A-FC4B52D71E69Q52688122-CDF1DEA6-1F21-439B-BB08-0891699530B0Q53601791-05537D64-132E-4284-848C-1BA43B52737AQ54970116-8654BF3E-CFDD-488B-A238-66C3DA74F093Q55012882-C5B6FB1E-7CC0-474C-B148-B7303F14400CQ55411157-AD70BF6B-29F8-4ED6-B4B0-C6661C17DD34Q58699234-C5039E84-C756-40F6-B879-27A02DC982D8Q58795088-8CE22368-6685-4582-83BA-884ABF5A3109
P2860
Aspirin Use and Colorectal Cancer Survival According to Tumor CD274 (Programmed Cell Death 1 Ligand 1) Expression Status.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Aspirin Use and Colorectal Can ...... 1 Ligand 1) Expression Status.
@ast
Aspirin Use and Colorectal Can ...... 1 Ligand 1) Expression Status.
@en
type
label
Aspirin Use and Colorectal Can ...... 1 Ligand 1) Expression Status.
@ast
Aspirin Use and Colorectal Can ...... 1 Ligand 1) Expression Status.
@en
prefLabel
Aspirin Use and Colorectal Can ...... 1 Ligand 1) Expression Status.
@ast
Aspirin Use and Colorectal Can ...... 1 Ligand 1) Expression Status.
@en
P2093
P2860
P50
P356
P1476
Aspirin Use and Colorectal Can ...... 1 Ligand 1) Expression Status
@en
P2093
Andrew T Chan
Annacarolina da Silva
Daniel Nevo
Gordon J Freeman
Jonathan A Nowak
Juhong Yang
Keisuke Kosumi
Kosuke Mima
P2860
P304
P356
10.1200/JCO.2016.70.7547
P407
P577
2017-04-13T00:00:00Z